Picture of Dr. Gil Kaplan

Dr. Gil Kaplan

Pronouns: He/Him


Professor of Medicine

Cumming School of Medicine, Department of Medicine

Professor of Medicine

Cumming School of Medicine, Department of Community Health Sciences


Alberta Health Services

Full Member

The Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases

Contact information

Phone number

Office: +1 (403) 220-2293


Office: TRW3D03-18

For media enquiries, contact

Kelly Johnston
Senior Communications Specialist

Please submit your media request here



Educational Background

B.S. , McMaster University, 1997

Doctor of Medicine Medicine, University of Calgary, 2000

Master of Public Health Public Health, Harvard University, 2006


Dr. Kaplan is a Professor in the Cumming School of Medicine at the University of Calgary. Dr. Kaplan is a gastroenterologist and epidemiologist who is internationally renowned for studying the global epidemiology of digestive diseases. Dr. Kaplan’s research program establishes the global burden of digestive diseases, evaluates environmental determinates of the inflammatory bowel diseases (IBD), and translates this knowledge into improvement of care for patients living with digestive diseases. He graduated with a Master of Public Health from the Harvard School of Public Health and completed an IBD Fellowship at the Massachusetts General Hospital. He joined the University of Calgary in 2007 as a clinician-scientist with 80% protected time for research. He has over 260 publications with an H-index of 56 and over 15,000 lifetime citations (Publons, https://publons.com/researcher/4286726/gilaad-g-kaplan/metrics/). As nominated principal applicant, Dr. Kaplan has held multiple operating grants from CIHR with continuous funding spanning from 2008 to 2024. He is the past chair of the Scientific and Medical Advisory Counsel of Crohn’s and Colitis Canada (CCC), as well as the co-chair of CCC’s National COVID-IBD Task Force. He is the chair of the American Gastroenterological Association (AGA) International Subcommittee. He was inducted as a Fellow of the AGA and named by Healio Gastroenterology as one of the top 200 leading innovators in the field of gastroenterology. In 2019, Dr. Kaplan was elected to the International Organization of the study of IBD (IOIBD) and appointed co-chair of the Globalization IBD Task Force. In 2020, Clarivate, Web of Science named Dr. Kaplan a Highly Cited Researcher in recognition of being in the top one percent of cited researchers. In 2021, Dr. Kaplan was inducted into the Canadian Academy Health Sciences.


  • Fellow, Canadian Academy of Health Sciences. 2021
  • Highly Cited Researcher, Clarivate, Web of Science: Recognizes the top one percent of cited researchers (Cross Field). 2020
  • Watanabe Distinguished Achievement Award for Overall Excellence, University of Calgary. 2019